Buell Jennifer
Chief Executive Officer
Buell Jennifer has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Oct 14, 2026.
On the most recent filing, Buell Jennifer is listed as Chief Executive Officer at MiNK Therapeutics, Inc. Inside the rolling window, Buell Jennifer reported no open-market purchases and 1 open-market sale totaling $73K in INKT.
Companies traded
Other insiders at INKT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$73K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Buell Jennifer made?
Buell Jennifer has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Buell Jennifer trade?
Buell Jennifer has filed SEC Form 4 disclosures for 1 company, including INKT.
When was Buell Jennifer's most recent SEC Form 4 filing?
Buell Jennifer's most recent SEC Form 4 filing on Tracefour is dated Oct 14, 2026.
What is Buell Jennifer's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Buell Jennifer is listed as Chief Executive Officer.
What is Buell Jennifer's total buy and sell value in the current window?
Inside the rolling retention window, Buell Jennifer bought $0 and sold $73K based on SEC Form 4 filings.
What was Buell Jennifer's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,938 INKT shares on 2026-10-12, worth $73K, per SEC Form 4 filings.